Table I.
Comparison of pretreatment JMJD6-Ab level with clinicopathological factors.
| Variable | Low JMJD6-Ab group <5,720, n=106 (%) | High JMJD6-Ab group ≧5,720, n=61 (%) | P-valuea |
|---|---|---|---|
| Sex | 0.15 | ||
| Female | 49 (70) | 21 (30) | |
| Male | 57 (59) | 40 (41) | |
| Age, years | 0.03 | ||
| <65 | 52 (73) | 19 (27) | |
| ≥65 | 54 (56) | 42 (44) | |
| Tumor depth | 0.61 | ||
| pT1pT2 | 34 (67) | 17 (33) | |
| pT3pT4 | 72 (62) | 44 (38) | |
| Nodal status | 1 | ||
| Negative | 68 (64) | 39 (36) | |
| Positive | 38 (63) | 22 (37) | |
| Stage | 0.17 | ||
| I/II/III | 93 (62) | 58 (38) | |
| IV | 13 (81) | 3 (19) | |
| Distant metastasis | 0.26 | ||
| Negative | 94 (62) | 58 (38) | |
| Positive | 12 (80) | 3 (20) | |
| Histology | 0.65 | ||
| Muc, Poor | 4 (80.0) | 1 (20) | |
| Tub | 101 (63) | 60 (37) | |
| CEA, 5 ng/ml | 0.20 | ||
| Negative | 62 (68) | 29 (32) | |
| Positive | 44 (58) | 32 (42) | |
| CA19-9, 37 U/ml | 0.67 | ||
| Negative | 90 (64) | 50 (36) | |
| Positive | 16 (59) | 11 (41) | |
| p53-Abb | 0.34 | ||
| Negative | 79 (65) | 42 (35) | |
| Positive | 21 (55) | 17 (45) |
a
Fisher's exact probability test;
b
excluding eight untested cases. Muc, mucinous adenocarcinoma; Poor, poorly differentiated adenocarcinoma; Tub, tubular adenocarcinoma.